{"id":1291,"date":"2024-03-23T08:03:13","date_gmt":"2024-03-23T08:03:13","guid":{"rendered":"https:\/\/internationaljournalofmicrobialscience.com\/?page_id=1291"},"modified":"2024-03-23T08:03:13","modified_gmt":"2024-03-23T08:03:13","slug":"references-38","status":"publish","type":"page","link":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/references-38\/","title":{"rendered":"References"},"content":{"rendered":"
    \n
  1. Wittebole, X., De Roock, S., & Opal, S. M. (2014). A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.\u00a0Virulence<\/em>,\u00a05<\/em>(1),226\u2013235. https:\/\/doi.org\/10.4161\/viru.25991<\/u><\/li>\n
  2. Summers, W.C. (2004). Bacteriophage research early history<\/em>, p 528. In<\/em> Kutter E, Sulakvelidze A (ed), Bacteriophages: biology and applications. CRC Press, Boca Raton, FL.<\/li>\n
  3. Pires, D. P., Vilas Boas, D., Sillankorva, S., & Azeredo, J. (2015). Phage Therapy: a Step Forward in the Treatment of Pseudomonas aeruginosa Infections. \u00a0Journal of virology<\/em>,\u00a089<\/em>(15),7449\u20137456. https:\/\/doi.org\/10.1128\/JVI.00385-15<\/u><\/li>\n
  4. Twort, F. (1915). An investigation on the nature of ultramicroscopic viruses. Lancet, 11, <\/em>1241-1243.<\/li>\n
  5. d\u2019H\u00e9relle, F. (1917). Sur un microbe invisible antagoniste des bacilles dysent\u00e9riques. Comptes rendus de l\u2019Acad\u00e9mie des<\/em> Sciences, 165, <\/em>373-375.<\/li>\n
  6. Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014). Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.\u00a0 Nature biotechnology<\/em>,\u00a032<\/em>(11),1146\u20131150. https:\/\/doi.org\/10.1038\/nbt.3043<\/u><\/li>\n
  7. Chen, Z., Guo, L., Zhang, Y., et al. (2014). Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. The Journal of Clinical Investigation<\/em>, 124<\/em>(8):3391-3406. DOI: 1172\/jci72517<\/u><\/li>\n
  8. Citorik, R. J., Mimee, M., & Lu, T. K. (2014). Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases.\u00a0Nature biotechnology<\/em>,\u00a032<\/em>(11), 1141\u20131145. https:\/\/doi.org\/10.1038\/nbt.3011<\/u><\/li>\n
  9. Devlin, A. S., Marcobal, A., Dodd, D., Nayfach, S., Plummer, N., Meyer, T., Pollard, K. S., Sonnenburg, J. L., & Fischbach, M. A. (2016). Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota.\u00a0Cell host & microbe<\/em>,\u00a020<\/em>(6),709\u2013715. https:\/\/doi.org\/10.1016\/j.chom.2016.10.021<\/u><\/li>\n
  10. Kutateladze, M., & Adamia, R. (2010). Bacteriophages as potential new therapeutics to replace or supplement antibiotics.\u00a0 Trends in biotechnology<\/em>,\u00a028<\/em>(12), 591\u2013595. https:\/\/doi.org\/10.1016\/j.tibtech.2010.08.001<\/u><\/li>\n
  11. Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. T. (2010). Phage therapy in clinical practice: treatment of human infections.\u00a0Current pharmaceutical biotechnology<\/em>, \u00a011<\/em>(1), 69\u201386. https:\/\/doi.org\/10.2174\/138920110790725401<\/u><\/li>\n
  12. Lu, T. K., & Collins, J. J. (2007). Dispersing biofilms with engineered enzymatic bacteriophage.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a0104<\/em>(27),11197\u201311202. https:\/\/doi.org\/10.1073\/pnas.0704624104<\/u><\/li>\n<\/ol>\n
      \n
    1. Lu, T. K., & Collins, J. J. (2009). Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a0106<\/em>(12), 4629\u20134634. https:\/\/doi.org\/10.1073\/pnas.0800442106<\/u><\/li>\n
    2. Maynard, N. D., Birch, E. W., Sanghvi, J. C., Chen, L., Gutschow, M. V., & Covert, M. W. (2010). A forward-genetic screen and dynamic analysis of lambda phage host-dependencies reveals an extensive interaction network and a new anti-viral strategy.\u00a0PLoS genetics<\/em>, \u00a06<\/em>(7), e1001017. https:\/\/doi.org\/10.1371\/journal.pgen.1001017<\/u><\/li>\n
    3. Shen, T. C., Albenberg, L., Bittinger, K., Chehoud, C., Chen, Y. Y., Judge, C. A., Chau, L., Ni, J., Sheng, M., Lin, A., Wilkins, B. J., Buza, E. L., Lewis, J. D., Daikhin, Y., Nissim, I., Yudkoff, M., Bushman, F. D., & Wu, G. D. (2015). Engineering the gut microbiota to treat hyperammonemia.\u00a0The Journal of clinical investigation<\/em>,\u00a0125<\/em>(7),2841\u20132850. https:\/\/doi.org\/10.1172\/JCI79214<\/u><\/li>\n
    4. Mi\u0119dzybrodzki, R., Borysowski, J., Weber-D\u0105browska, B., Fortuna, W., Letkiewicz, S., Szufnarowski, K., Pawe\u0142czyk, Z., Rog\u00f3\u017c, P., K\u0142ak, M., Wojtasik, E., & G\u00f3rski, A. (2012). Clinical aspects of phage therapy.\u00a0Advances in virus research<\/em>,\u00a083<\/em>, 73\u2013121. https:\/\/doi.org\/10.1016\/B978-0-12-394438-2.00003-7<\/u><\/li>\n
    5. Dedrick, R. M., Guerrero-Bustamante, C. A., Garlena, R. A., Russell, D. A., Ford, K., Harris, K., Gilmour, K. C., Soothill, J., Jacobs-Sera, D., Schooley, R. T., Hatfull, G. F., & Spencer, H. (2019). Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus.\u00a0Nature medicine<\/em>, \u00a025<\/em>(5), 730\u2013733. https:\/\/doi.org\/10.1038\/s41591-019-0437-z<\/u><\/li>\n
    6. Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., Segall, A. M., Taplitz, R., Smith, D. M., Kerr, K., Kumaraswamy, M., Nizet, V., Lin, L., McCauley, M. D., Strathdee, S. A., Benson, C. A., \u2026 Hamilton, T. (2017). Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection.\u00a0Antimicrobial agents and chemotherapy<\/em>,\u00a0 61<\/em>(10), e00954-17. https:\/\/doi.org\/10.1128\/AAC.00954-17<\/u><\/li>\n
    7. C\u00e9line Verheust, Katia Pauwels, Jacques Mahillon, Donald R. Helinski, and Philippe Herman (2010). Contained Use of Bacteriophages: Risk Assessment and Biosafety Recommendations. Applied Biosafety, <\/em>15<\/em>(1), 32-44. 1177\/153567601001500106<\/u><\/li>\n
    8. Potera C. (2013). Phage renaissance: new hope against antibiotic resistance.\u00a0 Environmental health perspectives<\/em>,\u00a0121<\/em>(2),a48\u2013a53. https:\/\/doi.org\/10.1289\/ehp.121-a48<\/u><\/li>\n
    9. Matsuzaki S, Rashel M, Uchiyama J, Sakurai S, Ujihara T, Kuroda M, Ikeuchi M, Tani T, Fujieda M, Wakiguchi H, Imai S. (2005). Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases. J Infect Chemother<\/em> 11:211\u2013219. http:\/\/dx.doi.org\/10.1007\/s10156-005-0408-9<\/u><\/li>\n
    10. Kutateladze M, Adamia R. (2010). Bacteriophages as potential new therapeutics to replace or supplement antibiotics. \u00a0Trends Biotechnol<\/em> 28:591\u2013595. http:\/\/dx.doi.org\/10.1016\/j.tibtech.2010.08.001<\/a><\/li>\n<\/ol>\n
        \n
      1. Br\u00fcssow H. (2005). Phage therapy: the Escherichia coli experience.\u00a0Microbiology (Reading, England)<\/em>,\u00a0151<\/em>(Pt 7), 2133\u20132140. https:\/\/doi.org\/10.1099\/mic.0.27849-0<\/u><\/li>\n
      2. Bruttin, A., & Br\u00fcssow, H. (2005). Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy.\u00a0Antimicrobial agents and chemotherapy<\/em>,\u00a049<\/em>(7), 2874\u20132878. https:\/\/doi.org\/10.1128\/AAC.49.7.2874-2878.2005<\/u><\/li>\n
      3. Marza, J. A., Soothill, J. S., Boydell, P., & Collyns, T. A. (2006). Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa<\/em> infected patients.\u00a0Burns : journal of the International Society for Burn Injuries<\/em>,\u00a032<\/em>(5), 644\u2013646. https:\/\/doi.org\/10.1016\/j.burns.2006.02.012<\/u><\/li>\n
      4. Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K. (2016). Genetically Engineered Phages: a Review of Advances over the Last Decade.\u00a0Microbiology and molecular biology reviews:MMBR<\/em>,\u00a080<\/em>(3),523\u2013543. https:\/\/doi.org\/10.1128\/MMBR.00069-15<\/u><\/li>\n
      5. Marinelli, L. J., Hatfull, G. F., & Piuri, M. (2012). Recombineering: A powerful tool for modification of bacteriophage genomes.\u00a0 Bacteriophage<\/em>,\u00a02<\/em>(1),5\u201314. https:\/\/doi.org\/10.4161\/bact.18778<\/u><\/li>\n
      6. Citorik, R. J., Mimee, M., & Lu, T. K. (2014). Bacteriophage-based synthetic biology for the study of infectious diseases.\u00a0Current opinion in microbiology<\/em>,\u00a019<\/em>,59\u201369. https:\/\/doi.org\/10.1016\/j.mib.2014.05.022<\/u><\/li>\n
      7. Saeidi, N., Wong, C. K., Lo, T. M., Nguyen, H. X., Ling, H., Leong, S. S., Poh, C. L., & Chang, M. W. (2011). Engineering microbes to sense and eradicate Pseudomonas aeruginosa<\/em>, a human pathogen. \u00a0Molecular systems biology<\/em>,\u00a07<\/em>, 521. https:\/\/doi.org\/10.1038\/msb.2011.55<\/u><\/li>\n
      8. Bertozzi Silva, J., Storms, Z., & Sauvageau, D. (2016). Host receptors for bacteriophage adsorption.\u00a0FEMS microbiology letters<\/em>,\u00a0363<\/em>(4),fnw002. https:\/\/doi.org\/10.1093\/femsle\/fnw002<\/u><\/li>\n
      9. Cooper, C. J., Khan Mirzaei, M., & Nilsson, A. S. (2016). Adapting Drug Approval Pathways for Bacteriophage-Based Therapeutics.\u00a0Frontiers in microbiology<\/em>,\u00a07<\/em>, 1209. https:\/\/doi.org\/10.3389\/fmicb.2016.01209<\/u><\/li>\n
      10. Ando H, Lemire S, Pires DP, Lu TK. Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing. Cell Syst. 2015 Sep 23; 1(3):187-196. doi: 1016\/j.cels.2015.08.013<\/u> PMID: 26973885; PMCID: PMC4785837.<\/li>\n<\/ol>\n
          \n
        1. Chen, M., Zhang, L., Xin, S., Yao, H., Lu, C., & Zhang, W. (2017). Inducible Prophage Mutant of\u00a0Escherichia coli<\/em>Can Lyse New Host and the Key Sites of Receptor Recognition Identification.\u00a0 Frontiers in microbiology<\/em>, 8<\/em>, 147. https:\/\/doi.org\/10.3389\/fmicb.2017.00147<\/u><\/li>\n
        2. Gebhart, D., Williams, S. R., & Scholl, D. (2017). Bacteriophage SP6 encodes a second tail spike protein that recognizes Salmonella enterica<\/em> serogroups C2<\/sub>and C3<\/sub>.\u00a0Virology<\/em>,\u00a0507<\/em>, 263\u2013266. https:\/\/doi.org\/10.1016\/j.virol.2017.02.025<\/u><\/li>\n
        3. Hawkins, S. A., Layton, A. C., Ripp, S., Williams, D., & Sayler, G. S. (2008). Genome sequence of the Bacteroides fragilis phage ATCC 51477-B1.\u00a0Virology journal<\/em>,\u00a05<\/em>, 97. https:\/\/doi.org\/10.1186\/1743-422X-5-97<\/u><\/li>\n
        4. Heilpern AJ, Waldor MK. pIIICTX, a predicted CTXphi minor coat protein, can expand the host range of coliphage fd to include Vibrio cholerae<\/em>. J Bacteriol. 2003 Feb;185(3):1037-44. doi: 1128\/jb.185.3.1037-1044.2003<\/u> PMID: 12533480; PMCID: PMC142820.<\/li>\n
        5. Lin, T. Y., Lo, Y. H., Tseng, P. W., Chang, S. F., Lin, Y. T., & Chen, T. S. (2012). A T3 and T7 recombinant phage acquires efficient adsorption and a broader host range.\u00a0PloS one<\/em>,\u00a07<\/em>(2), e30954. https:\/\/doi.org\/10.1371\/journal.pone.0030954<\/u><\/li>\n
        6. Nguyen, A. H., Molineux, I. J., Springman, R., & Bull, J. J. (2012). Multiple genetic pathways to similar fitness limits during viral adaptation to a new host.\u00a0Evolution; international journal of organic evolution<\/em>,\u00a0 66<\/em>(2), 363\u2013374. https:\/\/doi.org\/10.1111\/j.1558-5646.2011.01433.x<\/u><\/li>\n
        7. Scholl, D., Cooley, M., Williams, S. R., Gebhart, D., Martin, D., Bates, A., & Mandrell, R. (2009). An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7.\u00a0Antimicrobial agents and chemotherapy<\/em>,\u00a0 53<\/em>(7), 3074\u20133080. https:\/\/doi.org\/10.1128\/AAC.01660-08<\/u><\/li>\n
        8. Yoichi, M., Abe, M., Miyanaga, K., Unno, H., & Tanji, Y. (2005). Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7.\u00a0Journal of biotechnology<\/em>,\u00a0115<\/em>(1), 101\u2013107. https:\/\/doi.org\/10.1016\/j.jbiotec.2004.08.003<\/u><\/li>\n
        9. Yosef, I., Goren, M. G., Globus, R., Molshanski-Mor, S., & Qimron, U. (2017). Extending the Host Range of Bacteriophage Particles for DNA Transduction.\u00a0Molecular cell<\/em>,\u00a066<\/em>(5), 721\u2013728.e3. https:\/\/doi.org\/10.1016\/j.molcel.2017.04.025<\/u><\/li>\n
        10. Labrie, S. J., Samson, J. E., & Moineau, S. (2010). Bacteriophage resistance mechanisms.\u00a0Nature reviews. Microbiology<\/em>,\u00a08<\/em>(5), 317\u2013327. https:\/\/doi.org\/10.1038\/nrmicro2315<\/u><\/li>\n
        11. Davies, J., & Davies, D. (2010). Origins and evolution of antibiotic resistance.\u00a0Microbiology and molecular biology reviews: MMBR<\/em>,\u00a0 74<\/em>(3), 417\u2013433. https:\/\/doi.org\/10.1128\/MMBR.00016-10<\/u><\/li>\n
        12. Dever, L. A., & Dermody, T. S. (1991). Mechanisms of bacterial resistance to antibiotics.\u00a0Archives of internal medicine<\/em>,\u00a0151<\/em>(5), 886\u2013895.<\/li>\n<\/ol>\n
            \n
          1. Neu H. C. (1992). The crisis in antibiotic resistance.\u00a0Science (New York, N.Y.)<\/em>,\u00a0 257 <\/em>(5073), 1064\u20131073. https:\/\/doi.org\/10.1126\/science.257.5073.1064<\/u><\/li>\n
          2. Wright, G. D., & Sutherland, A. D. (2007). New strategies for combating multidrug-resistant bacteria.\u00a0Trends in molecular medicine<\/em>,\u00a013<\/em>(6),260\u2013267. https:\/\/doi.org\/10.1016\/j.molmed.2007.04.004<\/u><\/li>\n
          3. Beck, A., Wurch, T., Bailly, C., & Corvaia, N. (2010). Strategies and challenges for the next generation of therapeutic antibodies.\u00a0Nature reviews. Immunology<\/em>,\u00a010<\/em>(5), 345\u2013352. https:\/\/doi.org\/10.1038\/nri2747<\/u><\/li>\n
          4. Foltz, I. N., Karow, M., & Wasserman, S. M. (2013). Evolution and emergence of therapeutic monoclonal antibodies: what cardiologists need to know.\u00a0Circulation<\/em>,\u00a0127<\/em>(22), 2222\u20132230. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002033<\/u><\/li>\n
          5. Gladstone, E. G., Molineux, I. J., & Bull, J. J. (2012). Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage.\u00a0Journal of biological engineering<\/em>,\u00a06<\/em>(1), 13. https:\/\/doi.org\/10.1186\/1754-1611-6-13<\/u><\/li>\n
          6. Lu, T. K., & Collins, J. J. (2007). Dispersing biofilms with engineered enzymatic bacteriophage.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a0104<\/em>(27),11197\u201311202. https:\/\/doi.org\/10.1073\/pnas.0704624104<\/u><\/li>\n
          7. Montag, D., Riede, I., Eschbach, M. L., Degen, M., & Henning, U. (1987). Receptor-recognizing proteins of T-even type bacteriophages. Constant and hypervariable regions and an unusual case of evolution.\u00a0Journal of molecular biology<\/em>,\u00a0196<\/em>(1),165\u2013174. https:\/\/doi.org\/10.1016\/0022-2836(87)90519-5<\/u><\/li>\n
          8. Pouillot, F., Blois, H., & Iris, F. (2010). Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria.\u00a0Biosecurity and bioterrorism : biodefense strategy, practice, and science<\/em>,\u00a0 8<\/em>(2), 155\u2013169. https:\/\/doi.org\/10.1089\/bsp.2009.0057<\/u><\/li>\n
          9. T\u00e9tart, F., Repoila, F., Monod, C., & Krisch, H. M. (1996). Bacteriophage T4 host range is expanded by duplications of a small domain of the tail fiber adhesin.\u00a0Journal of molecular biology<\/em>,\u00a0258<\/em>(5),726\u2013731. https:\/\/doi.org\/10.1006\/jmbi.1996.0281<\/u><\/li>\n
          10. Trojet, S. N., Caumont-Sarcos, A., Perrody, E., Comeau, A. M., & Krisch, H. M. (2011). The gp38 adhesins of the T4 superfamily: a complex modular determinant of the phage’s host specificity.\u00a0Genome biology and evolution<\/em>,\u00a03<\/em>, 674\u2013686. https:\/\/doi.org\/10.1093\/gbe\/evr059<\/u><\/li>\n<\/ol>\n
              \n
            1. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Water, P. (2007). Molecular biology of the cell<\/em> (5th ed.) Garland Science, New York, NY.<\/li>\n
            2. Snyder, L., Peters, J.E., Henkin, T.M., & Champness, W. (2013). Molecular genetics of bacteria<\/em> (4th ed.) ASM Press, Washington, DC.<\/li>\n
            3. Loessner, M. J., Rees, C. E., Stewart, G. S., & Scherer, S. (1996). Construction of luciferase reporter bacteriophage A511::luxAB for rapid and sensitive detection of viable Listeria cells.\u00a0Applied and environmental microbiology<\/em>,\u00a062<\/em>(4), 1133\u20131140. https:\/\/doi.org\/10.1128\/AEM.62.4.1133-1140.1996<\/u><\/li>\n
            4. Le, S., He, X., Tan, Y., Huang, G., Zhang, L., Lux, R., Shi, W., & Hu, F. (2013). Mapping the tail fiber as the receptor binding protein responsible for differential host specificity of Pseudomonas aeruginosa bacteriophages PaP1 and JG004.\u00a0PloS one<\/em>,\u00a0 8<\/em>(7), e68562. https:\/\/doi.org\/10.1371\/journal.pone.0068562<\/u><\/li>\n
            5. Ellis, H. M., Yu, D., DiTizio, T., & Court, D. L. (2001). High efficiency mutagenesis, repair, and engineering of chromosomal DNA using single-stranded oligonucleotides.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a098<\/em>(12), 6742\u20136746. https:\/\/doi.org\/10.1073\/pnas.121164898<\/u><\/li>\n
            6. Court, D. L., Sawitzke, J. A., & Thomason, L. C. (2002). Genetic engineering using homologous recombination. \u00a0Annual review of genetics<\/em>,\u00a036<\/em>, 361\u2013388. https:\/\/doi.org\/10.1146\/annurev.genet.36.061102.093104<\/u><\/li>\n
            7. Marinelli, L. J., Piuri, M., Swigonov\u00e1, Z., Balachandran, A., Oldfield, L. M., van Kessel, J. C., & Hatfull, G. F. (2008). BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes.\u00a0PloS one<\/em>,\u00a03<\/em>(12), e3957. https:\/\/doi.org\/10.1371\/journal.pone.0003957<\/u><\/li>\n
            8. Sharan, S. K., Thomason, L. C., Kuznetsov, S. G., & Court, D. L. (2009). Recombineering: a homologous recombination-based method of genetic engineering.\u00a0Nature protocols<\/em>,\u00a04<\/em>(2), 206\u2013223. https:\/\/doi.org\/10.1038\/nprot.2008.227<\/u><\/li>\n
            9. Oppenheim, A. B., Rattray, A. J., Bubunenko, M., Thomason, L. C., & Court, D. L. (2004). In vivo recombineering of bacteriophage lambda by PCR fragments and single-strand oligonucleotides.\u00a0Virology<\/em>,\u00a0319<\/em>(2),185\u2013189. https:\/\/doi.org\/10.1016\/j.virol.2003.11.007<\/u><\/li>\n
            10. Sarkis, G. J., Jacobs, W. R., Jr, & Hatfull, G. F. (1995). L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria.\u00a0Molecular microbiology<\/em>,\u00a015<\/em>(6),1055\u20131067. https:\/\/doi.org\/10.1111\/j.1365-2958.1995.tb02281.x<\/u><\/li>\n
            11. Tanji, Y., Furukawa, C., Na, S. H., Hijikata, T., Miyanaga, K., & Unno, H. (2004). Escherichia coli detection by GFP-labeled lysozyme-inactivated T4 bacteriophage.\u00a0 Journal of biotechnology<\/em>,\u00a0114<\/em>(1-2),11\u201320. https:\/\/doi.org\/10.1016\/j.jbiotec.2004.05.011<\/u><\/li>\n
            12. Yu, D., Ellis, H. M., Lee, E. C., Jenkins, N. A., Copeland, N. G., & Court, D. L. (2000). An efficient recombination system for chromosome engineering in Escherichia coli.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a097<\/em>(11),5978\u20135983. https:\/\/doi.org\/10.1073\/pnas.100127597<\/u><\/li>\n<\/ol>\n
                \n
              1. Copeland, N. G., Jenkins, N. A., & Court, D. L. (2001). Recombineering: a powerful new tool for mouse functional genomics.\u00a0Nature reviews. Genetics<\/em>,\u00a02<\/em>(10), 769\u2013779. https:\/\/doi.org\/10.1038\/35093556<\/u><\/li>\n
              2. Swaminathan, S., Ellis, H. M., Waters, L. S., Yu, D., Lee, E. C., Court, D. L., & Sharan, S. K. (2001). Rapid engineering of bacterial artificial chromosomes using oligonucleotides.\u00a0Genesis (New York, N.Y. : 2000)<\/em>,\u00a029<\/em>(1), 14\u201321. https:\/\/doi.org\/10.1002\/1526-968x(200101)29:1<14::aid-gene1001>3.0.co;2-x<\/u><\/li>\n
              3. Sarov, M., Schneider, S., Pozniakovski, A., Roguev, A., Ernst, S., Zhang, Y., Hyman, A. A., & Stewart, A. F. (2006). A recombineering pipeline for functional genomics applied to Caenorhabditis elegans.\u00a0Nature methods<\/em>,\u00a03<\/em>(10), 839\u2013844. https:\/\/doi.org\/10.1038\/nmeth933<\/u><\/li>\n
              4. Zhang, Y., Buchholz, F., Muyrers, J. P., & Stewart, A. F. (1998). A new logic for DNA engineering using recombination in Escherichia coli.\u00a0Nature genetics<\/em>,\u00a020<\/em>(2), 123\u2013128. https:\/\/doi.org\/10.1038\/2417<\/u><\/li>\n
              5. Muyrers, J. P., Zhang, Y., Testa, G., & Stewart, A. F. (1999). Rapid modification of bacterial artificial chromosomes by ET-recombination.\u00a0Nucleic acids research<\/em>,\u00a027<\/em>(6), 1555\u20131557. https:\/\/doi.org\/10.1093\/nar\/27.6.1555<\/u><\/li>\n
              6. Datsenko, K. A., & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a097<\/em>(12), 6640\u20136645. https:\/\/doi.org\/10.1073\/pnas.120163297<\/u><\/li>\n
              7. Piuri, M., & Hatfull, G. F. (2006). A peptidoglycan hydrolase motif within the mycobacteriophage TM4 tape measure protein promotes efficient infection of stationary phase cells.\u00a0Molecular microbiology<\/em>, \u00a062<\/em>(6), 1569\u20131585. https:\/\/doi.org\/10.1111\/j.1365-2958.2006.05473.x<\/u><\/li>\n
              8. Ranallo, R. T., Barnoy, S., Thakkar, S., Urick, T., & Venkatesan, M. M. (2006). Developing live Shigella vaccines using lambda Red recombineering.\u00a0FEMS immunology and medical microbiology<\/em>,\u00a047<\/em>(3),462\u2013469. https:\/\/doi.org\/10.1111\/j.1574-695X.2006.00118.x<\/u><\/li>\n
              9. Lopes, A., Amarir-Bouhram, J., Faure, G., Petit, M. A., & Guerois, R. (2010). Detection of novel recombinases in bacteriophage genomes unveils Rad52, Rad51 and Gp2.5 remote homologs.\u00a0Nucleic acids research<\/em>,\u00a038<\/em>(12), 3952\u20133962. https:\/\/doi.org\/10.1093\/nar\/gkq096<\/u><\/li>\n
              10. Levin, B. R., & Bull, J. J. (2004). Population and evolutionary dynamics of phage therapy.\u00a0Nature reviews. Microbiology<\/em>,\u00a02<\/em>(2),166\u2013173. https:\/\/doi.org\/10.1038\/nrmicro822<\/u><\/li>\n<\/ol>\n
                  \n
                1. Hagens, S., & Bl\u00e4si, U. (2003). Genetically modified filamentous phage as bactericidal agents: a pilot study.\u00a0Letters in applied microbiology<\/em>,\u00a0 37<\/em>(4), 318\u2013323. https:\/\/doi.org\/10.1046\/j.1472-765x.2003.01400.x<\/u><\/li>\n
                2. Fairhead H. (2009). SASP gene delivery: a novel antibacterial approach.\u00a0Drug news & perspectives<\/em>,\u00a022<\/em>(4), 197\u2013203. https:\/\/doi.org\/10.1358\/dnp.2009.22.4.1367708<\/u><\/li>\n
                3. Smartt, A. E., Xu, T., Jegier, P., Carswell, J. J., Blount, S. A., Sayler, G. S., & Ripp, S. (2012). Pathogen detection using engineered bacteriophages.\u00a0Analytical and bioanalytical chemistry<\/em>,\u00a0402<\/em>(10),3127\u20133146. https:\/\/doi.org\/10.1007\/s00216-011-5555-5<\/u><\/li>\n
                4. Wolber, P. K., & Green, R. L. (1990). Detection of bacteria by transduction of ice nucleation genes.\u00a0Trends in biotechnology<\/em>,\u00a08<\/em>(10),276\u2013279. https:\/\/doi.org\/10.1016\/0167-7799(90)90195-4<\/u><\/li>\n
                5. Edgar, R., McKinstry, M., Hwang, J., Oppenheim, A. B., Fekete, R. A., Giulian, G., Merril, C., Nagashima, K., & Adhya, S. (2006). High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a0103<\/em>(13), 4841\u20134845. https:\/\/doi.org\/10.1073\/pnas.0601211103<\/u><\/li>\n
                6. Smith, H. O., Hutchison, C. A., 3rd, Pfannkoch, C., & Venter, J. C. (2003). Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a0100<\/em>(26), 15440\u201315445. https:\/\/doi.org\/10.1073\/pnas.2237126100<\/u><\/li>\n
                7. Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., Benders, G. A., Montague, M. G., Ma, L., Moodie, M. M., Merryman, C., Vashee, S., Krishnakumar, R., Assad-Garcia, N., Andrews-Pfannkoch, C., Denisova, E. A., Young, L., Qi, Z. Q., Segall-Shapiro, T. H., Calvey, C. H., \u2026 Venter, J. C. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome.\u00a0Science (New York, N.Y.)<\/em>,\u00a0329<\/em>(5987),52\u201356. https:\/\/doi.org\/10.1126\/science.1190719<\/u><\/li>\n
                8. Gladstone, E. G., Molineux, I. J., & Bull, J. J. (2012). Evolutionary principles and synthetic biology: avoiding a molecular tragedy of the commons with an engineered phage.\u00a0Journal of biological engineering<\/em>,\u00a06<\/em>(1), 13. https:\/\/doi.org\/10.1186\/1754-1611-6-13<\/u><\/li>\n
                9. Westra, E. R., Buckling, A., & Fineran, P. C. (2014). CRISPR-Cas systems: beyond adaptive immunity.\u00a0Nature reviews. Microbiology<\/em>,\u00a012<\/em>(5),317\u2013326. https:\/\/doi.org\/10.1038\/nrmicro3241<\/u><\/li>\n
                10. Kiro, R., Shitrit, D., & Qimron, U. (2014). Efficient engineering of a bacteriophage genome using the type I-E CRISPR-Cas system.\u00a0RNA biology<\/em>,\u00a0 11<\/em>(1), 42\u201344. https:\/\/doi.org\/10.4161\/rna.27766<\/u><\/li>\n
                11. Chan, L. Y., Kosuri, S., & Endy, D. (2005). Refactoring bacteriophage T7.\u00a0Molecular systems biology<\/em>,\u00a01<\/em>, 2005.0018. https:\/\/doi.org\/10.1038\/msb4100025<\/u><\/li>\n<\/ol>\n
                    \n
                  1. Lu TK, Koeris MS, Chevalier B, Holder J, McKenzie G, Brownell D. May (2013). Recombinant phage and methods. US patent<\/em>, 13\/627,060.<\/li>\n
                  2. Curtin, J. J., & Donlan, R. M. (2006). Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.\u00a0Antimicrobial agents and chemotherapy<\/em>,\u00a050<\/em>(4),1268\u20131275. https:\/\/doi.org\/10.1128\/AAC.50.4.1268-1275.2006<\/u><\/li>\n
                  3. Sillankorva, S., Neubauer, P., & Azeredo, J. (2008). Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A.\u00a0BMC biotechnology<\/em>, \u00a08<\/em>, 79. https:\/\/doi.org\/10.1186\/1472-6750-8-79<\/u><\/li>\n
                  4. Sillankorva, S., Neubauer, P., & Azeredo, J. (2010). Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus.\u00a0Biofouling<\/em>,\u00a026<\/em>(5), 567\u2013575. https:\/\/doi.org\/10.1080\/08927014.2010.494251<\/u><\/li>\n
                  5. Fu, W., Forster, T., Mayer, O., Curtin, J. J., Lehman, S. M., & Donlan, R. M. (2010). Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system.\u00a0Antimicrobial agents and chemotherapy<\/em>,\u00a0 54 <\/em>(1), 397\u2013404. https:\/\/doi.org\/10.1128\/AAC.00669-09<\/u><\/li>\n
                  6. Rhoads, D. D., Wolcott, R. D., Kuskowski, M. A., Wolcott, B. M., Ward, L. S., & Sulakvelidze, A. (2009). Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial.\u00a0Journal of wound care<\/em>,\u00a018<\/em>(6), 237\u2013243. https:\/\/doi.org\/10.12968\/jowc.2009.18.6.42801<\/u><\/li>\n
                  7. McVay, C. S., Vel\u00e1squez, M., & Fralick, J. A. (2007). Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model.\u00a0Antimicrobial agents and chemotherapy<\/em>,\u00a051<\/em>(6), 1934\u20131938. https:\/\/doi.org\/10.1128\/AAC.01028-06<\/u><\/li>\n
                  8. Wright, A., Hawkins, C. H., Angg\u00e5rd, E. E., & Harper, D. R. (2009). A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.\u00a0Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery<\/em>,\u00a034<\/em>(4), 349\u2013357. https:\/\/doi.org\/10.1111\/j.1749-4486.2009.01973.x<\/u><\/li>\n
                  9. Carmody, L. A., Gill, J. J., Summer, E. J., Sajjan, U. S., Gonzalez, C. F., Young, R. F., & LiPuma, J. J. (2010). Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.\u00a0The Journal of infectious diseases<\/em>,\u00a0201<\/em>(2), 264\u2013271. https:\/\/doi.org\/10.1086\/649227<\/u><\/li>\n
                  10. Hawkins C, Harper D, Burch D, Angg\u00e5rd E, Soothill J. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before\/after clinical trial. Vet Microbiol. 2010 Dec 15;146(3-4):309-13. doi: 1016\/j.vetmic.2010.05.014.<\/u> Epub 2010 May 12. PMID: 20627620.<\/li>\n<\/ol>\n
                      \n
                    1. Fukuda, K., Ishida, W., Uchiyama, J., Rashel, M., Kato, S., Morita, T., Muraoka, A., Sumi, T., Matsuzaki, S., Daibata, M., & Fukushima, A. (2012). Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration.\u00a0PloS one<\/em>,\u00a07<\/em>(10), e47742. https:\/\/doi.org\/10.1371\/journal.pone.0047742<\/u><\/li>\n
                    2. Trigo, G., Martins, T. G., Fraga, A. G., Longatto-Filho, A., Castro, A. G., Azeredo, J., & Pedrosa, J. (2013). Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.\u00a0PLoS neglected tropical diseases<\/em>,\u00a07<\/em>(4), e2183. https:\/\/doi.org\/10.1371\/journal.pntd.0002183<\/u><\/li>\n
                    3. Samson, J. E., Magad\u00e1n, A. H., Sabri, M., & Moineau, S. (2013). Revenge of the phages: defeating bacterial defences.\u00a0Nature reviews.Microbiology<\/em>,\u00a011<\/em>(10),675\u2013687. https:\/\/doi.org\/10.1038\/nrmicro3096<\/li>\n
                    4. Lu, T. K., & Collins, J. J. (2009). Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a0106<\/em>(12), 4629\u20134634. https:\/\/doi.org\/10.1073\/pnas.0800442106<\/u><\/li>\n
                    5. Yoichi, M., Abe, M., Miyanaga, K., Unno, H., & Tanji, Y. (2005). Alteration of tail fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7.\u00a0Journal of biotechnology<\/em>,\u00a0115<\/em>(1), 101\u2013107. https:\/\/doi.org\/10.1016\/j.jbiotec.2004.08.003<\/u><\/li>\n
                    6. Heilpern AJ, Waldor MK. (2003). pIIICTX, a predicted CTXphi minor coat protein, can expand the host range of coliphage fd to include Vibrio<\/em> cholerae<\/em>. J Bacteriol<\/em> 185:1037\u20131044. http:\/\/dx.doi.org\/10.1128\/JB.185.3.1037-1044.2003<\/a><\/li>\n
                    7. Ando H, Lemire S, Pires DP, Lu TK. (2015). Engineering modular viral scaffolds for targeted bacterial population editing. Cell Syst<\/em> 1:187\u2013196. http:\/\/dx.doi.org\/10.1016\/j.cels.2015.08.013<\/u><\/li>\n
                    8. Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011). Phage treatment of human infections.\u00a0Bacteriophage<\/em>,\u00a01<\/em>(2), 66\u201385. https:\/\/doi.org\/10.4161\/bact.1.2.15845<\/u><\/li>\n
                    9. Loc-Carrillo, C., & Abedon, S. T. (2011). Pros and cons of phage therapy.\u00a0Bacteriophage<\/em>,\u00a01<\/em>(2),111\u2013114. https:\/\/doi.org\/10.4161\/bact.1.2.14590<\/u><\/li>\n
                    10. Paul, V. D., Sundarrajan, S., Rajagopalan, S. S., Hariharan, S., Kempashanaiah, N., Padmanabhan, S., Sriram, B., & Ramachandran, J. (2011). Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.\u00a0BMC microbiology<\/em>,\u00a011<\/em>,195. https:\/\/doi.org\/10.1186\/1471-2180-11-195<\/u><\/li>\n
                    11. Loessner M, Rees C, Stewart G, Scherer S. (1996). Construction of luciferase reporter bacteriophage A511::luxAB for rapid and sensitive detection of viable Listeria <\/em> Appl Environ Microbiol<\/em> 62:1133\u20131140.<\/li>\n
                    12. Piuri, M., Jacobs, W. R., Jr, & Hatfull, G. F. (2009). Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis.\u00a0PloS one<\/em>,\u00a0 4<\/em>(3), e4870. https:\/\/doi.org\/10.1371\/journal.pone.0004870<\/u><\/li>\n<\/ol>\n
                        \n
                      1. Bar, H., Yacoby, I., & Benhar, I. (2008). Killing cancer cells by targeted drug-carrying phage nanomedicines.\u00a0BMC biotechnology<\/em>,\u00a08<\/em>, 37. https:\/\/doi.org\/10.1186\/1472-6750-8-37<\/u><\/li>\n
                      2. Frenkel, D., & Solomon, B. (2002). Filamentous phage as vector-mediated antibody delivery to the brain.\u00a0Proceedings of the National Academy of Sciences of the United States of America<\/em>,\u00a099<\/em>(8),5675\u20135679. https:\/\/doi.org\/10.1073\/pnas.072027199<\/u><\/li>\n
                      3. Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004). HIV vaccine design and the neutralizing antibody problem.\u00a0Nature immunology<\/em>,\u00a05<\/em>(3), 233\u2013236. https:\/\/doi.org\/10.1038\/ni0304-233<\/u><\/li>\n
                      4. Sathaliyawala, T., Rao, M., Maclean, D. M., Birx, D. L., Alving, C. R., & Rao, V. B. (2006). Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.\u00a0Journal of virology<\/em>,\u00a0 80 <\/em>(15), 7688\u20137698. https:\/\/doi.org\/10.1128\/JVI.00235-06<\/u><\/li>\n
                      5. Ren, Z. J., Tian, C. J., Zhu, Q. S., Zhao, M. Y., Xin, A. G., Nie, W. X., Ling, S. R., Zhu, M. W., Wu, J. Y., Lan, H. Y., Cao, Y. C., & Bi, Y. Z. (2008). Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.\u00a0Vaccine<\/em>,\u00a026<\/em>(11),1471\u20131481. https:\/\/doi.org\/10.1016\/j.vaccine.2007.12.053<\/u><\/li>\n
                      6. Nam, K. T., Kim, D. W., Yoo, P. J., Chiang, C. Y., Meethong, N., Hammond, P. T., Chiang, Y. M., & Belcher, A. M. (2006). Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes.\u00a0Science (New York, N.Y.)<\/em>,\u00a0312<\/em>(5775), 885\u2013888. https:\/\/doi.org\/10.1126\/science.1122716<\/u><\/li>\n
                      7. Lee, Y. J., Yi, H., Kim, W. J., Kang, K., Yun, D. S., Strano, M. S., Ceder, G., & Belcher, A. M. (2009). Fabricating genetically engineered high-power lithium-ion batteries using multiple virus genes.\u00a0Science (New York, N.Y.)<\/em>,\u00a0324<\/em>(5930), 1051\u20131055. https:\/\/doi.org\/10.1126\/science.1171541<\/u><\/li>\n
                      8. Murugesan, M., Abbineni, G., Nimmo, S. L., Cao, B., & Mao, C. (2013). Virus-based photo-responsive nanowires formed by linking site-directed mutagenesis and chemical reaction.\u00a0Scientific reports<\/em>, \u00a03<\/em>, 1820. https:\/\/doi.org\/10.1038\/srep01820<\/u><\/li>\n
                      9. Rong, J., Lee, L. A., Li, K., Harp, B., Mello, C. M., Niu, Z., & Wang, Q. (2008). Oriented cell growth on self-assembled bacteriophage M13 thin films. Chemical communications (Cambridge, England)<\/em>, (41), 5185\u20135187. https:\/\/doi.org\/10.1039\/b811039e<\/u><\/li>\n<\/ol>\n
                          \n
                        1. Merzlyak, A., Indrakanti, S., & Lee, S. W. (2009). Genetically engineered nanofiber-like viruses for tissue regenerating materials.\u00a0 Nano letters<\/em>,\u00a0 9<\/em>(2), 846\u2013852. https:\/\/doi.org\/10.1021\/nl8036728<\/u><\/li>\n
                        2. Yoo, S. Y., Merzlyak, A., & Lee, S. W. (2014). Synthetic phage for tissue regeneration.\u00a0Mediators of inflammation<\/em>,\u00a02014<\/em>, 192790. https:\/\/doi.org\/10.1155\/2014\/192790<\/u><\/li>\n
                        3. Mao, C., Liu, A., & Cao, B. (2009). Virus-based chemical and biological sensing.\u00a0Angewandte Chemie (International ed. in English)<\/em>,\u00a048<\/em>(37),6790\u20136810. https:\/\/doi.org\/10.1002\/anie.200900231<\/u><\/li>\n
                        4. Lee, J. W., Song, J., Hwang, M. P., & Lee, K. H. (2013). Nanoscale bacteriophage biosensors beyond phage display.\u00a0International journal of nanomedicine<\/em>,\u00a08<\/em>, 3917\u20133925. https:\/\/doi.org\/10.2147\/IJN.S51894<\/u><\/li>\n
                        5. Yi, H., Ghosh, D., Ham, M. H., Qi, J., Barone, P. W., Strano, M. S., & Belcher, A. M. (2012). M13 phage-functionalized single-walled carbon nanotubes as nanoprobes for second near-infrared window fluorescence imaging of targeted tumors.\u00a0Nano letters<\/em>, \u00a012<\/em>(3), 1176\u20131183. https:\/\/doi.org\/10.1021\/nl2031663<\/u><\/li>\n
                        6. Lee, S. W., Mao, C., Flynn, C. E., & Belcher, A. M. (2002). Ordering of quantum dots using genetically engineered viruses.\u00a0Science (New York, N.Y.)<\/em>,\u00a0296<\/em>(5569), 892\u2013895. https:\/\/doi.org\/10.1126\/science.1068054<\/u><\/li>\n
                        7. Lee, S.W., Wood, B.M., & Belcher, A.M. (2003). Chiral smectic C structures of virus-based films. Langmuir<\/em>, 19<\/em> (5):1592\u20131598. http:\/\/dx.doi.org\/10.1021\/la026387w<\/u><\/li>\n
                        8. Lee, S.W., Lee, S.K., & Belcher, A.M. (2003). Virus-based alignment of inorganic, organic, and biological nanosized materials. Adv Mater<\/em>, 15<\/em>(9):689\u2013692. http:\/\/dx.doi.org\/10.1002\/adma.200304818<\/u><\/li>\n
                        9. Ni, J., Lee, S.W., White, J.M., & Belcher, A.M. (2004). Molecular orientation of a ZnS-nanocrystal-modified M13 virus on a silicon substrate. J Polym Sci Part B Polym Phys<\/em>, 42<\/em>(4):629\u2013635. http:\/\/dx.doi.org\/10.1002\/polb.10754<\/a><\/li>\n
                        10. Nam, K.T., Peelle, B.R., Lee, S.W., & Belcher, A.M. (2004). Genetically driven assembly of nanorings based on the M13 virus. Nano Lett<\/em>, 4<\/em>(1):23\u201327. http:\/\/dx.doi.org\/10.1021\/nl0347536<\/u><\/li>\n
                        11. Lee, S.W., & Belcher, A.M. (2004). Virus-based fabrication of micro- and nanofibers using electrospinning. Nano Lett<\/em>, 4<\/em>(3):387\u2013390. http:\/\/dx.doi.org\/10.1021\/nl034911t<\/u><\/li>\n
                        12. Nam, K. T., Kim, D. W., Yoo, P. J., Chiang, C. Y., Meethong, N., Hammond, P. T., Chiang, Y. M., & Belcher, A. M. (2006). Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes.\u00a0Science (New York, N.Y.)<\/em>,\u00a0312<\/em>(5775), 885\u2013888. https:\/\/doi.org\/10.1126\/science.1122716<\/u><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                          Wittebole, X., De Roock, S., & Opal, S. M. (2014). A historical overview of bacteriophage…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/pages\/1291"}],"collection":[{"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/comments?post=1291"}],"version-history":[{"count":1,"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/pages\/1291\/revisions"}],"predecessor-version":[{"id":1292,"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/pages\/1291\/revisions\/1292"}],"wp:attachment":[{"href":"https:\/\/internationaljournalofmicrobialscience.com\/index.php\/wp-json\/wp\/v2\/media?parent=1291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}